1. Home
  2. LQDA vs SIG Comparison

LQDA vs SIG Comparison

Compare LQDA & SIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$37.68

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Signet Jewelers Limited

SIG

Signet Jewelers Limited

HOLD

Current Price

$95.12

Market Cap

3.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
SIG
Founded
2004
1950
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.6B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
LQDA
SIG
Price
$37.68
$95.12
Analyst Decision
Strong Buy
Buy
Analyst Count
10
7
Target Price
$38.60
$108.14
AVG Volume (30 Days)
1.9M
810.1K
Earning Date
11-03-2025
12-02-2025
Dividend Yield
N/A
1.35%
EPS Growth
N/A
N/A
EPS
N/A
3.42
Revenue
$69,216,000.00
$6,821,100,000.00
Revenue This Year
$1,005.03
$2.26
Revenue Next Year
$204.13
$1.58
P/E Ratio
N/A
$27.79
Revenue Growth
343.41
N/A
52 Week Low
$11.26
$45.55
52 Week High
$41.57
$110.20

Technical Indicators

Market Signals
Indicator
LQDA
SIG
Relative Strength Index (RSI) 60.22 60.37
Support Level $29.41 $82.22
Resistance Level $41.57 $94.00
Average True Range (ATR) 3.03 3.75
MACD 0.43 1.15
Stochastic Oscillator 68.38 89.21

Price Performance

Historical Comparison
LQDA
SIG

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

About SIG Signet Jewelers Limited

Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.

Share on Social Networks: